5GWK
Human topoisomerase IIalpha in complex with DNA and etoposide
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | NSRRC BEAMLINE BL13C1 |
Synchrotron site | NSRRC |
Beamline | BL13C1 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2011-09-04 |
Detector | ADSC QUANTUM 315r |
Wavelength(s) | 0.97622 |
Spacegroup name | P 21 2 21 |
Unit cell lengths | 105.113, 126.155, 198.856 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 27.488 - 3.152 |
R-factor | 0.2046 |
Rwork | 0.203 |
R-free | 0.24370 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 3qx3 |
RMSD bond length | 0.002 |
RMSD bond angle | 0.566 |
Data reduction software | HKL-2000 |
Data scaling software | HKL-2000 |
Phasing software | PHENIX |
Refinement software | PHENIX (1.9_1692) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 27.488 | 3.200 |
High resolution limit [Å] | 3.150 | 3.150 |
Number of reflections | 45909 | |
<I/σ(I)> | 24.6 | |
Completeness [%] | 99.2 | |
Redundancy | 6.7 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 277 | Magnesium Acetate, 2-(N-morpholino)ethanesulfonic acid, 2-methyl-2,4-pentanediol |